CA2087844A1 - Recepteur de cannabinoide - Google Patents

Recepteur de cannabinoide

Info

Publication number
CA2087844A1
CA2087844A1 CA002087844A CA2087844A CA2087844A1 CA 2087844 A1 CA2087844 A1 CA 2087844A1 CA 002087844 A CA002087844 A CA 002087844A CA 2087844 A CA2087844 A CA 2087844A CA 2087844 A1 CA2087844 A1 CA 2087844A1
Authority
CA
Canada
Prior art keywords
receptor
cannabinoid receptor
cannabinoid
protein
recombinant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002087844A
Other languages
English (en)
Inventor
Lisa A. Matsuda
Michael J. Brownstein
Tom I. Bonner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Commerce
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2087844A1 publication Critical patent/CA2087844A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA002087844A 1990-08-08 1991-08-08 Recepteur de cannabinoide Abandoned CA2087844A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56407590A 1990-08-08 1990-08-08
US564,075 1990-08-08

Publications (1)

Publication Number Publication Date
CA2087844A1 true CA2087844A1 (fr) 1992-02-09

Family

ID=24253065

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002087844A Abandoned CA2087844A1 (fr) 1990-08-08 1991-08-08 Recepteur de cannabinoide

Country Status (5)

Country Link
EP (1) EP0542920A4 (fr)
JP (1) JPH05507417A (fr)
AU (1) AU645609B2 (fr)
CA (1) CA2087844A1 (fr)
WO (1) WO1992002640A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6573794A (en) * 1993-04-27 1994-11-21 Medical Research Council Cannabinoid receptor expressed in cells of the immune system
FR2714580B1 (fr) * 1993-12-30 1996-02-09 Seb Sa Accessoire de coiffure pour appareil à sécher les cheveux.
CN1315437A (zh) * 2000-03-29 2001-10-03 上海博德基因开发有限公司 一种新的多肽——人大麻醇受体蛋白19和编码这种多肽的多核苷酸
CN1323822A (zh) * 2000-05-16 2001-11-28 上海博德基因开发有限公司 一种新的多肽——人中枢大麻成分受体22和编码这种多肽的多核苷酸
SE0202240D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Genes
SE0202242D0 (sv) * 2002-07-17 2002-07-17 Astrazeneca Ab Compounds
EP2722669A1 (fr) 2012-10-22 2014-04-23 Securetec Detektions-Systeme AG Procédé et dispositif destinés à la vérification de drogues illégales
WO2020232350A1 (fr) * 2019-05-15 2020-11-19 The Regents Of The University Of Colorado, A Body Corporate Dosages pour cannabinoïdes synthétiques
WO2024022478A1 (fr) * 2022-07-28 2024-02-01 长春金赛药业有限责任公司 Anticorps se liant au récepteur cannabinoïde cb1 et son utilisation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01273582A (ja) * 1988-04-26 1989-11-01 Matsushita Electric Ind Co Ltd モノクローナル抗体産生細胞ライン及びモノクローナル抗体及び免疫原
JPH068399B2 (ja) * 1988-08-10 1994-02-02 東洋製罐株式会社 製缶用塗料
JPH0257178A (ja) * 1988-08-22 1990-02-26 Matsushita Electric Ind Co Ltd モノクローナル抗体産生細胞ラインおよびモノクローナル抗体

Also Published As

Publication number Publication date
AU645609B2 (en) 1994-01-20
EP0542920A4 (en) 1993-07-14
JPH05507417A (ja) 1993-10-28
AU8543091A (en) 1992-03-02
WO1992002640A1 (fr) 1992-02-20
EP0542920A1 (fr) 1993-05-26

Similar Documents

Publication Publication Date Title
CA2071879C (fr) Compositions et methodes pour le recepteur du glutamate
Shapiro et al. Characterization and functional expression in mammalian cells of genomic and cDNA clones encoding a Drosophila muscarinic acetylcholine receptor.
JP4216326B2 (ja) ヒト神経ペプチドｙ／ペプチドｙｙ／膵臓ポリペプチド受容体（ｙ４）をコードしたｄｎａ、及び該ｄｎａの使用
US5288607A (en) Polypeptides having a β-adrenergic receptor activity in man, implicated in the lipolytic response, nucleic acids coding for these polypeptides and the use of these polypeptides for the screening of a substance active on these polypeptides
WO1994028131A1 (fr) Adn codant des canaux potassiques kga actives par la proteine g et servant de regulateurs internes chez les mammiferes, et son utilisation
US7510846B2 (en) Assay employing human or rat GAL-R2 galanin receptor
Duman et al. Development of β-adrenergic receptor and G protein messenger RNA in rat brain
CA2087844A1 (fr) Recepteur de cannabinoide
US5789196A (en) Recombinantly produced β4 neuronal nicotinic acetylcholine receptor subunits
US20090226436A1 (en) Novel receptors
WO2002042458A2 (fr) Nouveaux recepteurs
WO2002000719A2 (fr) Nouveaux recepteurs
Miotto et al. Molecular characterization of opioid receptors
US6576742B1 (en) DNA sequence encoding a human imidazoline receptor and method for cloning the same
WO2001068704A2 (fr) Recepteurs couples a la proteine g
AU2001245675A1 (en) G-protein coupled receptors
US6635741B1 (en) G-protein coupled receptor BCA-GPCR-3
US5945509A (en) Glutamate receptor compositions and method
US20020111473A1 (en) Novel g protein coupled receptor
US20030139589A1 (en) G protein coupled receptor A4
CA2284857A1 (fr) Recepteur a4 couple a une proteine g

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead